Drug points: Benign intracranial hypertension secondary to nasal fluticasone propionate.
Bond
D W
DW
Department of Child Health, Queen's Medical Centre, University Hospital, Nottingham NG7 2UH, UK.
Charlton
C P
CP
Gregson
R M
RM
D000281:Administration, Intranasal; D000293:Adolescent; D000730:Androstadienes / Q000008:administration & dosage / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001416:Back Pain / Q000139:chemically induced; D000068298:Fluticasone; D005938:Glucocorticoids; D006261:Headache / Q000139:chemically induced; D006801:Humans; D019586:Intracranial Hypertension / Q000139:chemically induced*; D008297:Male; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy
D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D000068298:Fluticasone